Increasing the size of the specific pathogen free Indian rhesus macaques colony at the Southwest National Primate Research Center for AIDS, COVID-19 and other infectious diseases research

Information

  • Research Project
  • 10313857
  • ApplicationId
    10313857
  • Core Project Number
    P51OD011133
  • Full Project Number
    3P51OD011133-23S1
  • Serial Number
    011133
  • FOA Number
    PA-20-272
  • Sub Project Id
  • Project Start Date
    6/6/1999 - 25 years ago
  • Project End Date
    4/30/2026 - a year from now
  • Program Officer Name
    HILD, SHERI ANN
  • Budget Start Date
    5/15/2021 - 3 years ago
  • Budget End Date
    4/30/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    23
  • Suffix
    S1
  • Award Notice Date
    5/18/2021 - 3 years ago

Increasing the size of the specific pathogen free Indian rhesus macaques colony at the Southwest National Primate Research Center for AIDS, COVID-19 and other infectious diseases research

Abstract. Specific pathogen free (SPF) Indian origin Macaca mulatta (rhesus macaques) are the premier model for infectious disease research including HIV/AIDS, TB, influenza, Lyme disease, and now COVID-19. There has been an acute nationwide shortage of these animals over the past couple of decades, which has been well- documented. Multiple reasons related to the COVID-19 pandemic have made this situation more difficult. Imports of these animals from Asia have stopped, and biomedical corporates have used large number of these animals in the past year. A number of animals have also been used in COVID-19 research by investigators at virtually each of the seven National Primate Research Centers (NPRCs). Hence, there is an acute, urgent need to increase the availability of SPF Indian origin rhesus macaques. This application proposes to increase the production of these animals at the Southwest National Primate Research Center (SNPRC).

IC Name
OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH
  • Activity
    P51
  • Administering IC
    OD
  • Application Type
    3
  • Direct Cost Amount
    894342
  • Indirect Cost Amount
  • Total Cost
    894342
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    855
  • Ed Inst. Type
  • Funding ICs
    NIAID:894342\
  • Funding Mechanism
    RESEARCH CENTERS
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    TEXAS BIOMEDICAL RESEARCH INSTITUTE
  • Organization Department
  • Organization DUNS
    007936834
  • Organization City
    SAN ANTONIO
  • Organization State
    TX
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    782275302
  • Organization District
    UNITED STATES